Iovance Biotherapeutics, Inc. share price logo

Iovance Biotherapeutics, Inc. Share Price

NASDAQ: IOVA

Small Cap

$3.58

-0.11

(-2.98%)

Live

as on

Iovance Biotherapeutics, Inc. Stock Performance

as on March 28, 2026 at 5:09 am IST

  • Day's Low

    Day's High

    $3.56
    $3.71
    downward going graph

    0.56%

    Downside

    3.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.64
    $5.63
    downward going graph

    54.23%

    Downside

    57.26%

    Upside

    downward going graph

Iovance Biotherapeutics, Inc. share price movements today

Previous Close
$3.69
Open
$3.66
Volume
5.6M
Day's Low - High
$3.56 - $3.71
52 Week Low - High
$1.64 - $5.63

Iovance Biotherapeutics, Inc. Historical Returns

1 Month Return
-4.4 %
3 Month Return
+ 29.47 %
1 Year Return
+ 1.65 %
3 Year Return
-40 %
5 Year Return
-87.13 %

Iovance Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Check Iovance Biotherapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-0.5023

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-362.3M

Revenue (TTM)

263.5M

Profit Margin

-148.38%

Return On Equity TTM

-55.50%

Iovance Biotherapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Iovance Biotherapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Iovance Biotherapeutics, Inc. image
Iovance Biotherapeutics, Inc.
BUY$1.5B-87.13%NA-148.38%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$43.6B140.85%141.078.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.6B111.4%29.6832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.6BNA114.765.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$79.2B58.67%18.0831.41%

Stock Returns calculator for Iovance Biotherapeutics, Inc. Stock including INR - Dollar returns

The Iovance Biotherapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Iovance Biotherapeutics, Inc. investment value today

Current value as on today

₹1,09,132

Returns

₹9,132

(+9.13%)

Returns from Iovance Biotherapeutics, Inc. Stock

₹1,377 (-1.38%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Iovance Biotherapeutics, Inc. Stock

Based on 20 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 20 analysts, 90% of analysts recommend a 'BUY' rating for Iovance Biotherapeutics, Inc.. Average target price of $9

Iovance Biotherapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Iovance Biotherapeutics, Inc..

What analysts predicted

60.22%UPSIDE

Target Price

$9

Current Price

$3.58

Analyzed by

20 Analysts

Target

$9.00

Iovance Biotherapeutics, Inc. target price $9, a slight upside of 60.22% compared to current price of $3.58. According to 20 analysts rating.

Iovance Biotherapeutics, Inc. Stock’s Investor Sentiment and Interest

Investment in Iovance Biotherapeutics, Inc. Shares on INDmoney has grown by 48.27% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:48.27% versus previous 30 day period

Search interest for Iovance Biotherapeutics, Inc. Stock has increased by 111% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:111% versus previous 30 day period

Iovance Biotherapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
31
58
73
49
59
67
86
Gross Profit
-3
-3
-6
0
18
28
0
3
66
187
Operating Income
-118
-121
-117
-101
-89
-86
-121
-113
-94
-73
EBITDA
-108
-111
-107
-91
-77
-74
-106
-101
-84
-67
Interest Expense
-
3
-
-
-
-
-
-
-
-
Depreciation
9
9
9
10
11
11
11
11
11
12
Income Before Tax
-115
-118
-114
-98
-85
-77
-118
-109
-93
-71
Income Tax Expense
-1
-1
-1
-1
-1
1
-1
1
-2
0
Net Income
-113
-116
-112
-97
-83
-78
-116
-111
-91
-71
Net Profit Margin
-24255.86%
-24145.02%
-15800.84%
-312.16%
-142.67%
-106.60%
-235.51%
-186.25%
-135.28%
-82.87%

Iovance Biotherapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
0
1
164
263
Gross Profit
0
0
0
-8
-8
-13
-21
-9
40
256
Operating Income
-53
-92
-128
-206
-261
-342
-398
-460
-395
-403
EBITDA
-52
-91
-127
-205
-260
-328
-377
-427
-351
-357
Interest Expense
-
-
-
-
2
0
2
-
-
-
Depreciation
-
0
0
1
1
13
21
29
43
47
Income Before Tax
-52
-92
-123
-197
-259
-342
-395
-447
-375
-393
Income Tax Expense
0
0
4
-10
-2
-14
-5
-3
-2
-2
Net Income
-52
-92
-123
-187
-259
-327
-389
-444
-372
-390
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-163833.19%
-37345.42%
-226.84%
-148.38%

Iovance Biotherapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-116
-112
-97
-83
-78
-116
-111
-91
-71
Operating Cash Flow
-83
-122
-98
-58
-73
-103
-67
-78
-52
Investing Cash Flow
-72
-111
40
-48
23
15
13
17
0
Financing Cash Flow
0
193
152
41
2
143
13
88
56
Change in Cash
-152
-40
94
-64
-48
55
-39
25
4

Iovance Biotherapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-92
-123
-197
-259
-342
-395
-444
-372
-390
Operating Cash Flow
-78
-101
-158
-205
-227
-292
-361
-352
-302
Investing Cash Flow
58
-386
90
-317
0
256
-155
-96
47
Financing Cash Flow
58
424
6
576
239
190
462
390
300
Change in Cash
38
-63
-62
53
11
153
-56
-59
47

Global Institutional Holdings in Iovance Biotherapeutics, Inc.

Funds
Holdings
Bank of America Corp
1.52%
Morgan Stanley - Brokerage Accounts
1.35%
BlackRock Inc
6.3%
Geode Capital Management, LLC
1.94%
Goldman Sachs Group Inc
1.31%
See all

Insights on Iovance Biotherapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, IOVA stock has moved up by 29.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 19.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 72.3% return, outperforming this stock by 112.3%

About Iovance Biotherapeutics, Inc.

iovance biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (til). this approach, also known as adoptive t-cell therapy, was initially developed by dr. steven a. rosenberg at the national cancer institute (nci). in phase 2 clinical trials conducted at the nci, 56% and 24% of patients treated with this technology were reported by nci to have achieved objective and complete response criteria, respectively. our lead product candidate is an autologous, ready-to-infuse cell therapy, that has demonstrated distinctive efficacy in the treatment of metastatic melanoma. in addition to metastatic melanoma, carcinoma of the head and neck and cervical cancer our til therapy technology is potentially applicable to many other tumor types, including ovarian, breast, bladder, colorectal and other cancers. as we continue advancing our current clinical programs through the introduction of manufacturing and logistical
OrganisationIovance Biotherapeutics, Inc.
Headquarters825 Industrial Road, San Carlos, CA, United States, 94070
IndustryHealth Technology
CEODr. Frederick G. Vogt Esq., J.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Iovance Biotherapeutics, Inc.

Name

Title

Dr. Igor P. Bilinsky Ph.D.

Chief Operating Officer

Dr. Friedrich Graf Finckenstein M.D.

Chief Medical Officer

Dr. Raj K. Puri M.D., Ph.D.

Chief Regulatory Officer

Ms. Corleen M. Roche

Chief Financial Officer

Mr. Matthew W. Rosinack

Principal Accounting Officer

Ms. Sara Pellegrino

Senior Vice President of Investor Relations & Corporate Communications

Mr. Brian Shew M.B.A.

Senior VP & Head of Digital and Information Technology

Dr. Frederick G. Vogt Esq., J.D., Ph.D.

Interim CEO, President, General Counsel, Corporate Secretary & Director

Ms. Tracy Winton

Executive Vice President of Human Resources

Mr. Howard B. Johnson M.B.A.

Chief Business Officer

FAQs

What is Iovance Biotherapeutics, Inc. share price today?

Iovance Biotherapeutics, Inc. share price today is $3.58 as on . Iovance Biotherapeutics, Inc. share today touched a day high of $3.71 and a low of $3.56.

What is the 52 week high and 52 week low for Iovance Biotherapeutics, Inc. share?

Iovance Biotherapeutics, Inc. share touched a 52 week high of $5.63 on and a 52 week low of $1.64 on . Iovance Biotherapeutics, Inc. stock price today i.e. is trending at $3.58,which is 36.41% down from its 52 week high and 118.49% up from its 52 week low.

What is Iovance Biotherapeutics, Inc.'s market capitalisation today?

Iovance Biotherapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Iovance Biotherapeutics, Inc. Stock (IOVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Iovance Biotherapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Iovance Biotherapeutics, Inc. Shares that will get you 0.4190 shares as per Iovance Biotherapeutics, Inc. share price of $3.58 per share as on March 27, 2026 at 11:39 pm IST.

What is the minimum amount required to buy Iovance Biotherapeutics, Inc. Stock (IOVA) from India?

Indian investors can start investing in Iovance Biotherapeutics, Inc. (IOVA) shares with as little as ₹94.651 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Iovance Biotherapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Iovance Biotherapeutics, Inc. share’s latest price of $3.58 as on March 27, 2026 at 11:39 pm IST, you will get 2.7933 shares of Iovance Biotherapeutics, Inc.. Learn more about fractional shares .

What are the returns that Iovance Biotherapeutics, Inc. has given to Indian investors in the last 5 years?

Iovance Biotherapeutics, Inc. stock has given -87.13% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?